Showing 1 - 20 results of 28 for search '"menopause"', query time: 0.07s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Menopause, reproductive life, hormone replacement therapy, and bone phenotype at age 60-64 years: a British birth cohort by Kuh, D, Muthuri, S, Cooper, R, Moore, A, Mackinnon, K, Cooper, C, Adams, J, Hardy, R, Ward, K

    Published 2016
    “…Previous studies of menopausal age and length of reproductive life on bone are limited by retrospective reproductive histories, being cross-sectional, or lacking gold standard bone technologies or information on hormone replacement therapy (HRT) or surgical treatment.The objective of the study was to investigate age at menopause, length of reproductive life, and HRT use in relation to volumetric and areal bone mineral density (vBMD, aBMD), bone size, and strength in women aged 60-64 years.This was a birth cohort study that followed up for 64 years with prospective measures of age at menarche and menopause and monthly HRT histories.The study was conducted in England, Scotland, and Wales.Participants included 848 women with a known type of menopause and bone measures at 60-64 years.Peripheral quantitative computed tomography measurements of the distal radius total and trabecular vBMD were measured. …”
    Journal article
  5. 5
  6. 6

    Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women. by Liu, B, Balkwill, A, Cooper, C, Roddam, A, Brown, A, Beral, V

    Published 2009
    “…The adjusted relative risk (RR) of hip and knee replacement for osteoarthritis was examined in relation to parity, age at menarche, menopausal status, age at menopause and use of hormonal therapies. …”
    Journal article
  7. 7

    Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis. by Cooper, C, Emkey, R, McDonald, R, Hawker, G, Bianchi, G, Wilson, K, Schimmer, R

    Published 2003
    “…A multicenter, randomized, double-blind, noninferiority study was conducted in 235 women (53-80 yr old; time since menopause >/==" BORDER="0"> 3 yr) with postmenopausal osteoporosis [lumbar spine (L1-L4) bone mineral density (BMD) T-score …”
    Journal article
  8. 8

    The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. by Yoshimura, N, Kasamatsu, T, Sakata, K, Hashimoto, T, Cooper, C

    Published 2002
    “…Participants with ovariectomy or hysterectomy were excluded, and the remaining participants were categorized into four groups: premenopausal ( n = 38), perimenopausal ( n = 14), postmenopausal group 1 (5 years or less since menopause; n = 18), and postmenopausal group 2 (6 years or more since menopause; n = 74). …”
    Journal article
  9. 9

    Who is at risk of osteoporosis? by Dennison, E, Medley, J, Cooper, C

    Published 2006
    “…Some risk factors for fragility fracture act through bone mineral density (BMD), for example female gender, asian or Caucasian race, premature menopause, primary or secondary amenorrhoea, primary and secondary hypogonadism in men, prolongued immobilisation, low dietary calcium intake, vitamin D deficiency. …”
    Journal article
  10. 10

    Cigarette smoking, birthweight and osteoporosis in adulthood: results from the hertfordshire cohort study. by Moinuddin, M, Jameson, K, Syddall, H, Sayer, A, Martin, H, Robinson, S, Cooper, C, Dennison, E

    Published 2008
    “…Participants completed a health questionnaire, and bone densitometry (DXA) of the lumbar spine and femoral neck performed.We found no relationships between cigarette and alcohol consumption, physical activity and either BMC or BMD after adjustment for age, body mass index, dietary calcium, social class, HRT use and years since menopause. However, male current smokers in the lowest third of birth weight had lower femoral neck BMD than ex- or never smokers from the lowest birth weight third (p value for interaction term = 0.04). …”
    Journal article
  11. 11

    Epidemiology of fractures and assessment of fracture risk. by Black, D, Cooper, C

    Published 2000
    “…Sex hormone deficiency after the menopause is a key factor in the pathogenesis of osteoporosis in women. …”
    Journal article
  12. 12

    Assessment of cardiovascular safety of anti-osteoporosis drugs by Fuggle, NR, Cooper, C, Harvey, NC, Al-Daghri, N, Brandi, M-L, Bruyere, O, Cano, A, Dennison, EM, Diez-Perez, A, Kaufman, J-M, Palacios, S, Prieto Alhambra, D, Rozenberg, S, Thomas, T, Tremollieres, F, Rizzoli, R, Kanis, JA, Reginster, JY

    Published 2020
    “…Despite findings in the early 21st century that menopausal hormone therapy was associated with coronary artery disease and venous thromboembolism (VTE), this therapy is now thought to be potentially safe (from a cardiac perspective) if started within the first 10 years of the menopause. …”
    Journal article
  13. 13

    Obesity is not protective against fracture in postmenopausal women: GLOW. by Compston, J, Watts, N, Chapurlat, R, Cooper, C, Boonen, S, Greenspan, S, Pfeilschifter, J, Silverman, S, Díez-Pérez, A, Lindsay, R, Saag, K, Netelenbos, J, Gehlbach, S, Hooven, F, Flahive, J, Adachi, J, Rossini, M, Lacroix, A, Roux, C, Sambrook, P, Siris, E

    Published 2011
    “…Obese women with fracture were more likely to have experienced early menopause and to report 2 or more falls in the past year. …”
    Journal article
  14. 14

    Risk of new vertebral fracture in the year following a fracture. by Lindsay, R, Silverman, S, Cooper, C, Hanley, D, Barton, I, Broy, S, Licata, A, Benhamou, L, Geusens, P, Flowers, K, Stracke, H, Seeman, E

    Published 2001
    “…RESULTS: Subjects were a mean age of 74 years and had a mean of 28 years since menopause. The cumulative incidence of new vertebral fractures in the first year was 6.6%. …”
    Journal article
  15. 15

    Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. by Prieto-Alhambra, D, Judge, A, Javaid, M, Cooper, C, Diez-Perez, A, Arden, N

    Published 2014
    “…CONCLUSIONS: The effect of age is greatest in the elderly for knee and hip OA, but around the menopause for hand OA. OA clusters within individuals, with higher risk of incident knee and hip disease from prevalent lower limb and hand OA.…”
    Journal article
  16. 16

    Is screening for osteoporosis worthwhile? by Walker-Bone, K, Reid, D, Cooper, C

    Published 1998
    “…On current evidence, it is certainly not appropriate to target hormone replacement therapy for women at the menopause on the basis of a bone density screening programme. …”
    Journal article
  17. 17

    Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. by Edwards, M, Gregson, C, Patel, H, Jameson, K, Harvey, N, Sayer, A, Dennison, E, Cooper, C

    Published 2013
    “…These associations were also seen in men and were maintained after adjustment for age, height, weight-adjusted-for-height, limb-length-adjusted-for-height, social class, smoking status, alcohol consumption, calcium intake, physical activity, diabetes mellitus, and in women, years since menopause and estrogen replacement therapy. Although grip strength showed similar associations with bone size and strength in both sexes, these were substantially attenuated after similar adjustment. …”
    Conference item
  18. 18

    Peripheral quantitative computed tomography measures are associated with adult fracture risk: the Hertfordshire Cohort Study. by Dennison, E, Jameson, K, Edwards, M, Denison, H, Aihie Sayer, A, Cooper, C

    Published 2014
    “…Among women, radial cortical thickness (HR 1.72, 95% CI 1.16, 2.54, p=0.007) and cortical area (HR 1.91, 95% CI 1.27, 2.85, p=0.002) at the 66% slice were both associated with incident fractures; these results remained significant after adjustment for confounders (age, BMI, social class, cigarette smoking and alcohol consumption, physical activity, dietary calcium, HRT and years since menopause). Further adjustment for aBMD made a little difference to the results. …”
    Journal article
  19. 19

    A study of relationships between single nucleotide polymorphisms from the growth hormone-insulin-like growth factor axis and bone mass: the Hertfordshire cohort study. by Dennison, E, Syddall, H, Jameson, K, Sayer, A, Gaunt, T, Rodriguez, S, Day, I, Cooper, C, Lips, M

    Published 2009
    “…In women, the mean BMC lumbar spine within the GHRH 11 genotype was 56.9 g, while that of the GHRH 12 genotype was 68.4 g [p < 0.001, fully adjusted for age, body mass index, cigarette and alcohol consumption, dietary calcium intake, physical activity, years since menopause, and hormone replacement therapy (HRT) use]; corresponding figures for BMD lumbar spine (GHRH 11 genotype) were 0.96 g/cm(2) versus 1.10 g/cm(2) (p < 0.001 fully adjusted). …”
    Journal article
  20. 20

    The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study. by Gregson, C, Sayers, A, Lazar, V, Steel, S, Dennison, E, Cooper, C, Smith, G, Rittweger, J, Tobias, J

    Published 2013
    “…HBM cases had substantially greater trabecular density at the distal tibia (340 [320, 359] mg/cm(3)), compared to both family (294 [276, 312]) and population controls (290 [281, 299]) (p<0.001 for both, adjusted for age, gender, weight, height, alcohol, smoking, malignancy, menopause, steroid and estrogen replacement use). Similar results were obtained at the distal radius. …”
    Journal article